Safety of polyethylene glycol 3350 for the treatment of chronic constipation in children

DS Pashankar, V Loening-Baucke… - Archives of pediatrics & …, 2003 - jamanetwork.com
Objectives To assess the clinical and biochemical safety profile of long-term polyethylene
glycol 3350 (PEG) therapy in children with chronic constipation and to assess pediatric …

Current treatment options for chronic constipation.

JA DiPalma - Reviews in gastroenterological disorders, 2004 - europepmc.org
Various agents are used for the medical management of chronic constipation but few have
been carefully studied. This review examines available data concerning several bulk and …

Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome

RW Chapman, V Stanghellini, M Geraint… - Official journal of the …, 2013 - journals.lww.com
OBJECTIVES: Polyethylene glycol (PEG) 3350 plus electrolytes (PEG 3350+ E) is an
established treatment for constipation and has been proposed as a treatment option for …

Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children

DS Pashankar, WP Bishop - The Journal of pediatrics, 2001 - Elsevier
Objective: To determine efficacy, safety, and optimal dose of a laxative, polyethylene glycol
(PEG) 3350, in children with chronic constipation. Study design: Children with chronic …

A randomised, double-blind study of polyethylene glycol 4000 and lactulose in the treatment of constipation in children

S Treepongkaruna, N Simakachorn, P Pienvichit… - BMC pediatrics, 2014 - Springer
Background Chronic constipation is frequent in children. The objective of this study is to
compare the efficacy and safety of PEG 4000 and lactulose for the treatment of chronic …

[HTML][HTML] Review of the treatment options for chronic constipation

JF Johanson - Medscape General Medicine, 2007 - ncbi.nlm.nih.gov
Constipation is a common gastrointestinal motility disorder that is often chronic, negatively
affects patients' daily lives, and is associated with high healthcare costs. There is a …

Randomised clinical trial: macrogol/PEG 3350+ electrolytes versus prucalopride in the treatment of chronic constipation‐a comparison in a controlled environment

R Cinca, D Chera, HJ Gruss… - Alimentary pharmacology …, 2013 - Wiley Online Library
Background Constipation is a common condition for which PEG 3350 is an established
treatment and prucalopride has recently been approved for this indication. Aim To compare …

Management of chronic constipation in patients with diabetes mellitus

VGM Prasad, P Abraham - Indian Journal of Gastroenterology, 2017 - Springer
Aim The aim of this review is to provide an overview of the clinical assessment and evidence-
based treatment options for managing diabetes-associated chronic constipation. Methods A …

The treatment of chronic constipation in adults: a systematic review

SM Tramonte, MB Brand, CD Mulrow… - Journal of General …, 1997 - Wiley Online Library
OBJECTIVE: To evaluate whether laxatives and fiber therapies improve symptoms and
bowel movement frequency in adults with chronic constipation. DATA SOURCES: English …

The LUCK study: Laxative Usage in patients with GP-diagnosed Constipation in the UK, within the general population and in pregnancy. An epidemiological study …

ACE Shafe, S Lee, JSO Dalrymple… - Therapeutic …, 2011 - journals.sagepub.com
Background: Despite the high prevalence of constipation and its related public health
implications, there is relatively little research available on the condition from large …